Introducing The Neocision System
Empowering surgeons and radiologists with an innovative, minimally invasive solution to streamline breast cancer diagnosis and treatment to address a $2 billion global market.
A Smarter Approach to Tissue Excision
The Neocision System revolutionizes breast tissue excision by providing a minimally invasive, single-step procedure that eliminates wire localization, significantly reduces procedure time, and reduces risk of seeding metastasis.
Handheld, battery-powered system
Comprising a reusable Handpiece and a single-use Wand, the system allows for a fully automated tissue excision process under ultrasound guidance.
Precision excision with real-time imaging
The operator selects a capture diameter (15-30mm), ensuring targeted removal while preserving surrounding tissue.
Quick and efficient
The entire excision procedure is completed in less than 15 minutes, with tissue capture taking just 20 seconds.
Patient friendly
The procedure can be performed under local anesthetic, eliminating the need for general anesthesia and reducing hospital time.
Why The Neocision System is needed
Each year, millions of women undergo breast biopsy and breast-conserving surgery (BCS), commonly known as lumpectomy. While BCS is an effective approach to treating breast cancer, it comes with significant challenges:
Complex, multi-step process
Traditional BCS requires a two-step process involving wire localization in radiology and surgical excision under general anesthesia in an operating room.
May require a second surgery
Approximately 20% of patients require re-excision due to absence of clear margins between lesion and surface of excised tissue.
Our Solution
The Neocision System is a minimally invasive solution that reduces scarring and discomfort while delivering faster procedures, taking less than 15 minutes compared to over an hour for traditional lumpectomy. By eliminating the need for general anesthesia, the system allows for outpatient procedures, making breast tissue excision more accessible and efficient.
Neocision’s precision ensures fewer repeat surgeries, achieving clear margins and reducing the need for re-excision. Additionally, the system is cost-effective, minimizing hospital and operating room expenses while improving overall workflow efficiency.
The Future of Breast Cancer Treatment is Here
Neocision Medical is seeking Series A investment of $5 million to advance:
By partnering with us, you support the next-generation solution that will redefine breast cancer treatment to establish a new standard of care for breast cancer by making procedures faster, more precise and less invasive as well as reducing the requirement for additional surgery.